Seventure Partners — Full Portfolio
18 tracked investments · listed companies and verified rows first
Cytoki Pharma is a clinical-stage biotechnology company developing IL-22-based medicines for metabolic diseases such as obesity and type 2 diabetes, and conditions involving epithelial injury like inflammatory bowel disease.
BiotechHealthtechVærløse, DK
Rasmus Jorgensen(Founder)
Co-investors+ND CapitalYsios Capital
Clinical-stage biotech company pioneering treatments for non-Hodgkin lymphoma and other diseases
Co-investorsPrimo Ventures
Expensya offers an expense management solution that automates expense report handling, giving finance teams control while reducing administrative burden on employees.
Enterprise SoftwareFintechSaaS
Co-investorsIsaiISAI GestionMAIF AvenirSilicon BadiaTDR
Graphene Enterprise develops biocide-free graphene-based coatings for marine vessels that reduce fuel consumption and emissions while managing biofouling on hulls and propellers.
CleantechClimate TechDeep TechNew MaterialsDartmouth, CA
Co-investorsFarvatn VentureTechstars
Global leader in automotive aftersales solutions; acquired Veact in Europe.
JobTeaser operates a career center platform integrated into the student portals of over 800 European schools and universities, listing internships, apprenticeships, and entry-level jobs.
EdTechFuture of WorkHR Tech
Co-investorsHighland EuropeKorelya CapitalAlvenIdinvest Partners
Karmen provides AI-powered scheduling software for construction projects that automatically generates and maintains project timelines by analyzing project documents and adapting to changes.
Construction TechPropTechSan Francisco, US
Jonas Ebrahimi(Founder)inNaman Wahi(Founder)in
Co-investorsY CombinatorBpifrance
Mailjet is an email platform providing a drag-and-drop marketing email editor, audience segmentation and automation, and a RESTful Email API and SMTP relay for transactional and marketing email at scale.
Developer ToolsMarketing TechSaaS
Co-investorsIris CapitalAlven Capital
Houston, US
MATTHEW PAUL COSTELLO(Executive Officer, Director)
Co-investorsAlpana VenturesMotion VenturesShift4Good
Social adtech firm expanding into the US market
Microbiotica develops defined live biotherapeutic products based on microbiome science for immuno-oncology and inflammatory bowel disease treatment.
BiotechHealthtechMedical Devices
Co-investorsCambridge Innovation CapitalDCVC (Data Collective)
Navabi is an online retailer of plus-size women's fashion, offering designer and contemporary clothing including evening wear, dresses, blouses, and Lagenlook styles from labels such as Roberto Cavalli, Kenzo, and Zizzi.
ConsumerDirect to ConsumerE-commerce
Co-investorsIndex VenturesDumont VentureSevenVentures
Nimble Sciences develops the SIMBA GI Platform, a swallowable capsule system that autonomously collects, seals, and preserves fluid biopsies from the small intestine to generate multi-omic datasets of the GI tract.
BiotechDigital HealthMedical Devices
Co-investorsFirst Spark Ventures, LlcFusionStartup TNTThin Air LabsUCeed FundsBoxOne Ventures
Otoqi operates a platform for vehicle logistics and fleet management, offering car transport (convoyage), repositioning, refueling, maintenance, and real-time tracking through a network of over 2,000 independent drivers.
Logistics & Supply ChainMobility & TransportationSaaS
Sebastien de Limon(Founder)in
Co-investorsCDP Venture CapitalAster CapitalVerve Ventures
French pioneer in sailboat refurbishment; Seventure took a stake to accelerate its growth.
Veact provides data-driven lead management and marketing software for the automotive industry, helping car manufacturers (OEMs), national sales companies, and dealerships identify revenue opportunities and increase customer lifetime value.
Marketing TechMobility & TransportationSaaS
Co-investorsBayern KapitalUVC PartnersSenovo
Vedanta Biosciences is a clinical-stage biotech developing Live Biotherapeutic Products (LBP) based on defined consortia of bacteria to treat serious gastrointestinal diseases, with an initial focus on preventing recurrent Clostridium difficile infection.
BiotechHealthtechCambridge, US
Bernat Olle(Executive Officer, Director)Daniel Couto(Executive Officer)Mark Mullikin(Executive Officer)Jeffrey Silber(Executive Officer)Christopher Viehbacher(Director)
BoardJohn LaMattina(Director)
Co-investorsAMR Action FundK2 HealthVenturesSalica InvestmentsBNP ParibasBNP Paribas Asset Management EuropeTullis
VorteX-io provides real-time hydrological monitoring services for water bodies using a network of measurement stations to track water height, velocity, and flow.
Climate TechData & InfrastructureIoT
Co-investorsAFI VenturesDaphni
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





